Association of insulin use with LV remodeling and clinical outcomes in diabetic patients with heart failure and reduced ejection fraction: assessed by cardiac MRI

Ke Shi,Ge Zhang,Hang Fu,Shan Huang,Hua-Yan Xu,Yue Gao,Rui Shi,Wei-Feng Yan,Wen-Lei Qian,Yuan Li,Ying-Kun Guo,Zhi-Gang Yang
DOI: https://doi.org/10.1186/s12933-023-01944-y
IF: 8.949
2023-08-05
Cardiovascular Diabetology
Abstract:Insulin is commonly used in type 2 diabetes mellitus (T2DM) to achieve glycemic control. However, recent evidence showed that insulin use is associated with poor outcomes in the context of heart failure (HF). Since heart failure with reduced ejection fraction (HFrEF) accounts for approximately 50% of cases in the general HF population, we aimed to evaluate the effect of insulin treatment on left ventricular (LV) remodeling and contractility abnormalities in a HFrEF cohort and assess whether insulin was a predictor of adverse outcomes in this entity.
cardiac & cardiovascular systems,endocrinology & metabolism
What problem does this paper attempt to address?